Profile
Luciano D'Adamio is the founder and chairman of RemeGenix, Inc. which is founded in 2006.
He is also the founder of Kappa Lifescience Ltd.
and Sienagen S R L.
Currently, he holds the position of Professor-Immunology & Microbiology at Albert Einstein College of Medicine, Inc.
Luciano D'Adamio active positions
| Companies | Position | Start |
|---|---|---|
| REMEGENIX, INC. | Founder | 28/04/2006 |
| Albert Einstein College of Medicine, Inc. | Corporate Officer/Principal | - |
Former positions of Luciano D'Adamio
| Companies | Position | End |
|---|---|---|
| Sienagen S R L | Founder | - |
| Kappa Lifescience Ltd. | Founder | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
RemeGenix, Inc.
 RemeGenix, Inc. Pharmaceuticals: MajorHealth Technology RemeGenix, Inc. is a biotechnology company, which engages in the development of drug MoBA which is used for treatment of Alzheimer's disease. Its product pipe lines include NoMAD, which is one of the preferred animal models used in the development of a variety of Alzheimer's and ementia drug development efforts and MoBA. The company was founded by Luciano D'Adamio and J. Kelly Ganjei on April 28, 2006 and is headquartered in Bethesda, MD. | Health Technology |
| Kappa Lifescience Ltd. | |
| Sienagen S R L |
- Stock Market
- Insiders
- Luciano D'Adamio
